Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $271.28, with a market capitalization of 654B. The stock trades at a price-to-earnings (P/E) ratio of 30.81 and offers a dividend yield of 1.99%.
During the trading session on 2026-09-01, Johnson & Johnson(JNJ) shares reached a daily high of $271.91 and a low of $267.02. At a current price of $271.28, the stock is +1.6% higher than the low and still -0.2% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 6.03M, versus its average volume of 6.48M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $276.47 and a low of $173.33.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $276.47 and a low of $173.33.
JNJ News
...
Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed signals, with the Discounted Cash Flow (DCF) in...
Investing Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story Both Johnson and Johnson and Procter & Gamble just refreshed decades...
Analyst ratings
73%
of 26 ratingsMore JNJ News
Stellantis (STLA) announced a senior leadership appointment, effective September 1. Stephanie Hartgrove has been appointed chief communications officer, reporti...
Key Points AbbVie continues to expand its portfolio in high-growth areas like immunology and neuroscience. Johnson & Johnson maintains a massive footprint acr...
Key Points Johnson & Johnson has increased its dividend for 64 consecutive years. Merck has raised its dividend for 26 consecutive years. Both drug companies...
I've done extensive searches for a dividend stock that investors can actually sleep well owning, and I keep coming back to Johnson & Johnson (JNJ -1.57%). Right...
Johnson & Johnson (JNJ) shares are trading against the backdrop of a fresh U.S. Food and Drug Administration approval for Imaavy, the first and only treatment s...
Key Points Imaavy can be used to treat patients aged 12 and older with warm autoimmune hemolytic anemia (wAIHA), a rare blood disease. It's the second FDA win...
Johnson & Johnson (NYSE: JNJ) received FDA approval for IMAAVY as the first treatment for adults with warm autoimmune hemolytic anemia, providing a new option f...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.